Armata Pharmaceuticals, Inc.
ARMP· NYSE
Released Nov 14, 2017, after the close
10-Q filed Nov 14, 2017, 45 days after period end · 0001144204-17-059027
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$779.00K | -$2.38M | $5.44M | $21.21M |
| EPS Diluted | -$0.09 | -$3.23 | -$0.30 | -$0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Armata Pharmaceuticals, Inc. · CIK 921114 · Engraved from SEC EDGAR